Gravar-mail: Do Older Patients with Metastatic Non-Small Cell Lung Cancer Also Benefit from First-Line Platinum-Based Doublet Chemotherapy?: Observations from a Pooled Analysis of 730 Prospectively-Treated Patients (Alliance Study A151622)